Industry News: VOLUME 4 ISSUE 7

NeuroOne Medical Technologies Corporation Enters into Exclusive Development and Distribution Agreement for Commercialization of Diagnostic EVO Cortical Electrode Eden Prairie, MN– July 22, 2020– NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces the execution

Volume 10, Issue 23: Nigel Williams, Founder, ELXR Smart Health Discusses Medical Travel Technology as Backbone for Telemedicine

Dear Colleagues, Medical Travel Today is excited to bring you an interview with Nigel Williams, Founder, ELXR Smart Health, who specializes in solving problems where existing healthcare systems are under imminent burden of growing volumes of health episodes and increasing costs. In this interview, Williams discusses his company and their role

Industry News: Volume 10, Issue 23

Economic analysis of the prevalence and clinical and economic burden of medication error in England By Rachel Ann Elliott, Elizabeth Camacho, Dina Jankovic, Mark J Sculpher, Rita Faria Qualitysafety.bmj.com - Medication is the most widely used medical intervention. Harm caused by medication is referred to as an adverse drug event (ADE), and includes medication errors,

VOLUME 4 ISSUE 6: Brian Klepper, Principal, Worksite Health Advisors, Discusses High Performing Health Organizations

Dear Colleagues, In this issue, I had the chance to speak with Brian Klepper, Principal, Worksite Health Advisors, a company finding and vetting health care companies that consistently deliver measurably better health outcomes at far lower costs than conventional approaches. In this interview, Klepper explains the benefits of using high-performing organizations,

Industry News: VOLUME 4 ISSUE 6

INDUSTRY NEWS  9 ways Covid-19 may forever upend the U.S. health care industry By Lev Facher statnews.com - In the U.S. alone, Covid-19 has claimed nearly 100,000 lives and 30 million jobs. Beyond grinding day-to-day life to a halt, the pandemic has prompted a reckoning throughout the country’s health care infrastructure, shattering decades-old assumptions

Volume 10, Issue 22: Mike Baldzicki, Executive Vice President, Growth & Strategy, AscellaHealth, Discusses Cost Savings Initiatives for Specialty Pharmacy Benefit Managers and Upcoming Webinar Series

Dear Colleagues, Medical Travel Today is excited to bring you an interview with Mike Baldzicki, Executive Vice President, Growth & Strategy at AscellaHealth, a national specialty pharmacy benefit manager serving commercial, Medicare and Medicaid segments, offering high quality prescription drug benefit management services. In this interview, Baldzicki discusses how employers and TPAs are

Spotlight Interview: Michael J. Baldzicki, CRCM Executive Vice President, Growth & Strategy, AscellaHealth

About Michael J Baldzicki, CRCM Executive Vice President, Growth & Strategy, AscellaHealth As an Executive of Growth & Strategy for AscellaHealth, Mike leads Market Access, Business Development & Corporate Strategy for Specialty / Infusion Pharmacy Segments, he provides business strategies of all portfolio management.  Within his roles, he ensures the success of

Industry News: Volume 10, Issue 22

INDUSTRY NEWS Johnson & Johnson to End Talc-Based Baby Powder Sales in North America By Tiffany Hsu and Roni Caryn Rabin nytimes.com - Johnson & Johnson is discontinuing North American sales of its talc-based baby powder, a product that once defined the company’s wholesome image and that it has defended for decades even as it faced